This federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract, valued at up to $2,750,000, is for the provision of hazardous pharmaceutical compounding and specialty pharmacy services to support VA oncology and infusion treatment programs nationwide.
Under this IDC, Avella will compound customized chemotherapy agents, hazardous sterile preparations, intravenous solutions, and other medications based on patient-specific orders for VA medical centers and clinics across the country. Avella operates as a 503A certified pharmacy, leveraging its expertise in aseptic techniques for hazardous drug preparation. The contract's period of performance runs through September 30, 2026. This unrestricted award allows the VA-VHA to issue task orders and calls for Avella's specialized pharmacy services as needed across various Veterans Integrated Service Networks (VISNs).
Generated 10/1/24, 9:12 AM